Hemolytic anemia in COVID-19 Hayder M. Al-kuraishyAli I. Al-GareebGaber El-Saber Batiha Review Article 08 July 2022 Pages: 1887 - 1895
Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence Sambhawana BhandariMaun Ranjan BaralOleg Sostin Review Article 27 June 2022 Pages: 1897 - 1904
Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study David CellaSujata P. SardaWilliam R. Lenderking Original Article Open access 23 July 2022 Pages: 1905 - 1914
Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart review Adam CukerLincy LalRicardo Viana Original Article 18 July 2022 Pages: 1915 - 1924
Adult Langerhans cell histiocytosis with thyroid gland involvement: clinical presentation, genomic analysis, and outcome Hua-cong CaiTing LiuXin-xin Cao Original Article 02 July 2022 Pages: 1925 - 1929
Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis Nadirah El-AminAudra InessOliver Karam Original Article 27 July 2022 Pages: 1931 - 1940
Frequency, pattern, and associations of renal iron accumulation in sickle/β-thalassemia patients Antonella MeloniLuigi BarbutoFilippo Cademartiri Original Article 11 July 2022 Pages: 1941 - 1950
Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort Eduardo Messias Hirano PadrãoBrian BustosLeandro Utino Taniguchi Original Article 15 July 2022 Pages: 1951 - 1957
An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19 Hideaki MatsuuraSumie FujiiYasuo Miura Original Article 14 July 2022 Pages: 1959 - 1969
Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria Raymond S. M. WongHumphrey W. H. PullonFederico V. Grossi Original Article Open access 22 July 2022 Pages: 1971 - 1986
Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing Madhavi MaddaliArvind VenkatramanPoonkuzhali Balasubramanian Original Article 15 July 2022 Pages: 1987 - 2000
Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis Shai ShimonyJonathan CanaaniOfir wolach Original Article 24 June 2022 Pages: 2001 - 2010
Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis Shai ShimonyJonathan CanaaniOfir wolach Correction 23 July 2022 Pages: 2011 - 2011
Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies Daisuke OgiyaNorie MurayamaHiroshi Yamazaki Original Article 22 June 2022 Pages: 2013 - 2019
Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma Fei QiYan XieJun Zhu Original Article 08 July 2022 Pages: 2021 - 2034
A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group Yi-Jin GaoYong-Jun FangJing-Yan Tang Original Article 13 July 2022 Pages: 2035 - 2043
Lowering platelet count threshold to 10,000/µL for peripherally inserted central catheter placement safely conserves blood products Roxana AmirahmadiScott SullivanMichael T. McCurdy Original Article 28 June 2022 Pages: 2045 - 2052
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients José Luis PiñanaPablo Rodríguez-BelenguerOn behalf of Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC) Original Article 02 July 2022 Pages: 2053 - 2067
Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted analysis Yosuke NakayaMika ImasakiTakahisa Yamane Original Article 02 July 2022 Pages: 2069 - 2077
Correction to: Peripherally inserted central venous catheters decrease central line‑associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score‑adjusted analysis Yosuke NakayaMika ImasakiTakahisa Yamane Correction 12 July 2022 Pages: 2079 - 2079
Hepatitis B reactivation during ruxolitinib treatment Marissa SjoblomHaithem ChtiouiSabine Blum Letter to the Editor 30 April 2022 Pages: 2081 - 2086
Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis Valentino DammassaAlessandra GrecoGuido Tavazzi Letter to the Editor 11 May 2022 Pages: 2087 - 2088
SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness Malte B. MoninBenjamin MarxAnnkristin Heine Letter to the Editor Open access 24 May 2022 Pages: 2089 - 2090
Neuroimaging of leptomeningeal myelomatosis: a rare and severe entity Teresa PerilloCarmela SommaAndrea Manto Letter to the Editor 07 May 2022 Pages: 2091 - 2092
Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia Benjamin PodvinHélène GuermoucheCatherine Roche-Lestienne Letter to the Editor 13 May 2022 Pages: 2093 - 2095
Increased blood levels of venetoclax due to intake of crushed venetoclax tablets Maiko AnzaiTakeo YasuMasayuki Kobayashi Letter to the Editor 26 May 2022 Pages: 2097 - 2098
Successful treatment of Kimura disease with benralizumab Vivian G. SzetoBenjamin Chin-YeeCyrus C. Hsia Letter to the Editor 27 May 2022 Pages: 2099 - 2100
The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia Xinhong YangRongjuan ZhangZhihua Zhang Letter to the Editor 15 June 2022 Pages: 2101 - 2102
Severe platelet transfusion refractoriness due to anti-HPA-5a antibody during induction chemotherapy for acute promyelocytic leukemia Kei SaitoSatoshi IchikawaTohru Izumi Letter to the Editor 25 May 2022 Pages: 2103 - 2105
Understanding the EKG changes in methemoglobinemia Pramukh Arun KumarMahati DasariAjay K. Mishra Letter to the Editor 20 June 2022 Pages: 2107 - 2110
Rhabdomyolysis induced by nelarabine Christian SpäthMandy SchönauWilliam H. Krüger Letter to the Editor Open access 17 June 2022 Pages: 2111 - 2112
A novel compound heterozygous mutation of von Hippel-Lindau gene in a Chinese patient with erythrocytosis Jun-Nan LiXiao-Hua LuoPing Li Letter to the Editor 29 June 2022 Pages: 2113 - 2114
Correction to: A novel compound heterozygous mutation of von Hippel‑Lindau gene in a Chinese patient with erythrocytosis Jun‑Nan LiXiao‑Hua LuoPing Li Correction 13 July 2022 Pages: 2115 - 2115
Serum levels of albumin and creatinine predict the outcome of sinusoidal obstruction syndrome after allogeneic HSCT Souichi ShiratoriKohei OkadaTakanori Teshima Letter to the Editor 20 June 2022 Pages: 2117 - 2118
Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma Yifei ZhangAmandeep GodaraAnkit Kansagra Letter to the Editor 12 July 2022 Pages: 2119 - 2121
